Gene · 406924
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNA as a Prognostic Marker in Small Lung Cell Carcinoma. | Genes (Basel) | 2025 | 41465138 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| MicroRNAs in neuroplasticity: a comprehensive review of mechanisms and therapeutic strategies for neurodegenerative diseases. | Neuroscience | 2025 | 40854343 | PubTator, text mining | PubMed |
| At the Pointy End of Mechanobiology: AFM for Transient Biomechanical Analysis. | Adv Healthc Mater | 2025 | 40847732 | PubTator, text mining | PubMed |
| LncRNA LINC01123-mediated impaired fracture healing through miR-134-5p/XIAP axis. | J Orthop Surg Res | 2025 | 40847361 | PubTator, text mining | PubMed |
| Modulation of miRNAs by Phytochemicals in Cerebral Ischemia: A Systematic Review of In Vitro and In Vivo Studies. | Phytother Res | 2025 | 40804606 | PubTator, text mining | PubMed |
| Differential Expression of hsa-miR-134, hsa-miR-155, hsa-miR-122 as Biomarkers of Epileptogenesis in Patients with Acute Cerebral Injury. | Biochemistry (Mosc) | 2025 | 40254402 | PubTator, text mining | PubMed |
| DMGAT: predicting ncRNA-drug resistance associations based on diffusion map and heterogeneous graph attention network. | Brief Bioinform | 2025 | 40251829 | PubTator, text mining | PubMed |
| Pharmacological Mechanism and Drug Research Prospects of Ginsenoside Rb1 as an Antidepressant. | Antioxidants (Basel) | 2025 | 40002422 | PubTator, text mining | PubMed |
| Inhibition of LGR5/β-Catenin Axis and Activation of miR134 Are Critically Involved in Apoptotic Effect of Sanggenol L in Hepatocellular Carcinoma. | Biol Pharm Bull | 2025 | 39956588 | PubTator, text mining | PubMed |
| Circulating miRNAs Associated With 3-Month Outcome in Patients With Acute Ischemic Stroke. | Neurology | 2025 | 39652811 | PubTator, text mining | PubMed |
| Integrating multiomics sequencing analyses uncover the key mechanisms related to oxidative stress, mitochondria, and immune cells in keloid. | Gene | 2025 | 39489224 | PubTator, text mining | PubMed |
| MicroRNAs as potential diagnostic biomarkers for bipolar disorder. | Neural Regen Res | 2025 | 39104098 | PubTator, text mining | PubMed |
| The role of miRNA134 in pathogenesis and treatment of intractable epilepsy: a review article. | Nucleosides Nucleotides Nucleic Acids | 2025 | 38531025 | PubTator, text mining | PubMed |
| Circulating miR-134 in mesial temporal lobe epilepsy: implications in hippocampal sclerosis development and drug resistance. | Front Mol Neurosci | 2024 | 39744540 | PubTator, text mining | PubMed |
| MicroRNAs as potential biomarkers of response to modified Atkins diet in treatment of adults with drug-resistant epilepsy: A proof-of-concept study. | Epilepsy Res | 2024 | 39536682 | PubTator, text mining | PubMed |
| Deciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review. | Heliyon | 2024 | 39435111 | PubTator, text mining | PubMed |
| Can Environmental Enrichment Modulate Epigenetic Processes in the Central Nervous System Under Adverse Environmental Conditions? A Systematic Review. | Cell Mol Neurobiol | 2024 | 39432132 | PubTator, text mining | PubMed |
| Bioinformatic Analysis from a Descriptive Profile of miRNAs in Chronic Migraine. | Int J Mol Sci | 2024 | 39408819 | PubTator, text mining | PubMed |
| [Evidence for Health Promotion in Brazil: report on a rapid response serviceEvidencia para la promoción de la salud en Brasil: informe sobre un servicio de respuesta rápida]. | Rev Panam Salud Publica | 2024 | 39247392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406924/papers?page=2